USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/10968
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPasnin, Ana
dc.contributor.authorTaburceanu, Elena
dc.contributor.authorVisnevschi, Anatolie
dc.date.accessioned2020-07-06T06:53:13Z
dc.date.available2020-07-06T06:53:13Z
dc.date.issued2016
dc.identifier.citationPASNIN, Ana, TABURCEANU, Elena, VISNEVSCHI, Anatolie. Serology in epstein-barr virus infection in children. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, p.49-50.en_US
dc.identifier.isbn978-9975-3028-3-8.
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/10968
dc.descriptionNicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova, Hospital for Infectious Diseases in Children, Chisinau, Moldova, Department of Laboratory Medicine, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016en_US
dc.description.abstractIntroduction: The Epstein-Barr virus was found in 1968 as the major cause of infectious mononucleosis. Since then the diagnosis of EBV has gone a way from the nonspecific tests, such as the heterophile antibody test, to specific EBV antibody tests performed through IFA, the “gold standard”, different immunoassay techniques, additional tests, used for confirmation such as avidity test and Western blot, to PCR, mainly used in patient with immunosuppression. The seroprevalence in adult population is wide, ranging from 85% in developed counties to 95-100% in developing counties. By age 5 seroprevalence in the UK and USA is 50%. In RM the incidence of mononucleosis has increased from 0.97 in 1992, to 2.97 in 2007. Although laboratory diagnosis in mononucleosis is straightforward and available, it still imposes some questions, due to high variability of EBV serology. The objective of this research is to study and discuss the challenges of laboratory diagnosis and staging of EBV infection based on serological profiles of the patients tested to EBV infection at the Hospital for Infectious Diseases in Children, in Chisinau, R. of Moldova during the year 2015. Materials and methods: the materials used are blood serum or plasma samples from 311 patients from 5 months old to 17 years old from the Hospital for Infectious Diseases in Children, who were consulted or admitted with suspected mononucleosis or hepatitis of unknown origin. Blood was tested to EBV-CA IgM and IgG, EA IgG, EBNA-1 IgG, anti CMV IgM and IgG, anti HAV IgM. The testing system used is the enzyme immunoassay. The interpretation of the results given by reagent manufacturers is: 1) Primary infection VCA IgM positive, VCA IgG pos/neg, EA IgG pos/neg, EBNA IgG negative, 2)Past infection VCA IgM negative, VCA IgG and EBNA IgG positive, 3)Reactivation VCA IgM, VCA IgG, EBNA IgG positive.Patients are categorized by their serology profile (VCA IgM and IgG, EBNA-1 IgG) in 3 main groups, patients with serology characteristic to acute infection, past infection, and patients with serology that can be interpreted either way. Discussion results: 209 blood samples were found positive to at least 1 marker of EBV infection. 114 had VCA IgM negative, VCA IgG and EBNA IgG positive. 34 were VCA IgM and IgG positive and EBNA IgG negative. 12 were VCA IgG positive VCA IgM and EBNA IgG negative, 25 were VCA IgG and IgM positive, EBNA IgG positive, 19 were VCA IgM positive, VCA IgG and EBNA IgG negative, and 4 were only EA IgG or EBNA IgG positive. Conclusion: 67.2% of samples were positive to EBV infection, which meant primary or past infection, 65.8% being children under age of 6 years. From them 54.5% had a serological pattern of pastinfection, 25.3% had indicators of primary infection, the rest (19.6%) had serological patterns that might have benefit from additional tests, such as avidity tests, western blot or PCR.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectinfectious mononucleosisen_US
dc.subjectchildrenen_US
dc.subjectlaboratory diagnosisen_US
dc.titleSerology in epstein-barr virus infection in children.en_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2016

Files in This Item:
File Description SizeFormat 
Serology_in_epstein_barr_virus_infection_in_children.PDF40 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback